![David Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David Perry worked as Senior Director-Business Development at Sangamo Therapeutics, Inc. Mr. Perry worked as Vice President-Business Development at Aligos Therapeutics, Inc. from 2024 to 2025.
Mr. Perry completed undergraduate education at Tufts University.
Anciens postes connus de David Perry
| Sociétés | Poste | Fin |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2025 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de David Perry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
